Glioblastoma with combined elevation of CD73 and CD39 (i.e., CD73hi/CD39hi tumors) were enriched for immune populations, while those with low levels of both enzymes (CD73loCD39lo) were depleted for nearly all immune cell populations. This evidence concerns the gene NT5E and glioblastoma.